Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer (Q38983831)

8 September 2017

title

Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer (English)

1 reference

8 September 2017

1 reference

Kirill Litovkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Steven Joniau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Evelyne Lerut

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Martin Spahn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Burkhard Kneitz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Sofie Isebaert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Karin Haustermans

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Monique Beullens

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Aleyde Van Eynde

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Mathieu Bollen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

18 June 2014

1 reference

Journal of Cancer Research and Clinical Oncology

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

1849-1861

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938434%20AND%20SRC:MED&resulttype=core&format=json

Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Methylation markers for prostate cancer prognosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

High-risk prostate cancer in the United States, 1990-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

DNA hypomethylation and activation of germline-specific genes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

The RASSF1A tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Screening, risk assessment, and the approach to therapy in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Regularization Paths for Generalized Linear Models via Coordinate Descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Five new human cancer‐germline genes identified among 12 genes expressed in spermatogonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Global methylation profiling for risk prediction of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaborati

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Epigenetic alterations in human prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Methylated genes as potential biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Qualified promise: DNA methylation assays for the detection and classification of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Validation of postoperative nomograms in prostate cancer patients with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1738-8

Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients

21 January 2018

1 reference

12 December 2020

EAU guidelines on prostate cancer

1 reference

12 December 2020

Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms

1 reference

12 December 2020

Promoter hypermethylation in prostate cancer

1 reference

12 December 2020

Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

1 reference

12 December 2020

DNA methylation of HOXD3 as a marker of prostate cancer progression

1 reference

12 December 2020

The contemporary concept of significant versus insignificant prostate cancer

1 reference

12 December 2020